Patient
SITE006-0178
withdrawn Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE006 (GBR) (Dr. Rossi)
consented 2026-03-30
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 6
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-11-19 (study day 40); relationship: not assessed
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-11-19 (study day 40); relationship: NOT RELATED
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-11-19 (study day 40); relationship: not assessed
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-11-10 (study day 31); relationship: not assessed
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-11-01 (study day 22); relationship: NOT RELATED
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-10-25 (study day 15); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.